已收盘 01-23 16:00:00 美东时间
-2.160
-3.11%
今日重点评级关注:HC Wainwright & Co.:维持Soleno Therapeutics"买入"评级,目标价从110美元升至120美元;富国银行:维持Soleno Therapeutics"超配"评级,目标价从106美元升至114美元
01-21 11:42
JP Morgan analyst Matthew Boss maintains Urban Outfitters (NASDAQ:URBN) with a Overweight and lowers the price target from $96 to $94.
01-20 23:24
今日重点评级关注:Guggenheim:维持MBX Biosciences"买入"评级,目标价从77美元升至88美元;摩根士丹利:维持DraftKings"超配"评级,目标价从50美元升至53美元
01-20 10:26
今日重点评级关注:HC Wainwright & Co.:维持NioCorp Developments"买入"评级,目标价从9.5美元升至11.25美元;摩根士丹利:维持Chewy"超配"评级,目标价从48美元升至51美元
01-14 11:25
Telsey Advisory Group analyst Dana Telsey maintains Urban Outfitters (NASDAQ:URBN) with a Outperform and maintains $98 price target.
01-13 20:01
Urban Outfitters, Inc. (NASDAQ:URBN), a leading lifestyle products and services company which operates a portfolio of global consumer brands including the Anthropologie, Free People, FP Movement, Urban Outfitters and
01-12 20:43
Urban Outfitters Inc. reported net sales for the two and eleven months ended December 31, 2025. Total Company net sales increased 9% for the two months and 11% for the eleven months compared to the prior year periods. Retail segment comparable net sales rose 5% for two months and 6% for eleven months, driven by mid-single-digit growth in both digital and retail store sales. Subscription segment sales grew 43% and 51% respectively, fueled by signi...
01-12 12:30
今日重点评级关注:巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从9美元升至10美元;摩根大通:上调Recursion Pharmaceuticals评级至"超配",目标价从10美元升至11美元
2025-12-18 10:54
Telsey Advisory Group analyst Dana Telsey upgrades Urban Outfitters (NASDAQ:URBN) from Market Perform to Outperform and raises the price target from $85 to $98.
2025-12-17 20:16
今日重点评级关注:Chardan Capital:维持Senti Biosciences"买入"评级,目标价从12美元升至13美元;Guggenheim:维持Praxis Precision Medicine"买入"评级,目标价从540美元升至760美元
2025-12-10 10:33